Navigation Links
STAAR Surgical Reports Solid First Quarter Progress
Date:5/6/2008

37% during the quarter and included $2,811,000 in sales from STAAR Japan. The impact of changes in currency on sales for the quarter was $1,137,000. Total U.S. sales for the first quarter were $4,524,000, down 11% compared with $5,094,000 in the same period last year. U.S. ICL sales were $1,100,000, up 9.3% as compared with $1,007,000 in the comparable period of 2007.

Gross profit margin was 43.2% compared with 48.9% in the first quarter of 2007. The decrease in margin was primarily due to the low margin associated with the step-up of inventory on the books of STAAR Japan in accounting for the acquisition, which impacted cost of sales by approximately $1.5 million during the quarter. Stepped-up inventory was sold during the quarter and the company expects STAAR Japan to realize gross margin that improves the Company's overall gross margin beginning in the second quarter.

General and Administrative Expenses were $4,441,000, which represents a 24% increase over the first quarter of 2007 of $3,583,000. The increase is due to incremental costs of STAAR Japan of $1,437,000 and increased legal expense in the U.S., partially offset by non-recurrence of the expenses of the Domilens investigation in Q1 2007.

Marketing and selling expenses were $6,467,000, which represents a 22% increase over the first quarter of 2007 of $5,302,000. International marketing and selling expenses increased 60% due to incremental costs of STAAR Japan of $875,000, increased marketing and selling costs to drive continued sales growth internationally, and the effect of exchange. U.S. marketing and selling expenses decreased 14% as compared to the first quarter of 2007 due to decreased commissions and promotional activities partially offset by increased salaries of the recently created direct sales force. U.S. marketing and selling expenses decreased 24% compared to the fourth quarter of 2007.

Research and development expenses were $1.7 million which represents a 7% increa
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. STAAR Surgical Announces First Quarter 2008 Earnings Release Date and Conference Call
2. STAAR Surgical Plans Major Presence at ASCRS
3. STAAR Surgical Reports Fourth Quarter and Year End Results
4. STAAR Surgicals Visian ICL Procedure Performed Live on NBCs Today show
5. STAAR Surgical Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
6. STAAR Surgical to Present at the Tenth Annual Needham Growth Conference
7. STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture
8. STAAR Surgical to Present at the BMO Capital Markets Focus on Healthcare Conference
9. Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical
10. STAAR Surgical Reports Third Quarter Results
11. STAAR Surgical to Purchase Canons Interest in Japanese Joint Venture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... HealthDay Reporter TUESDAY, July 29, ... are vital to good health and a long life, but ... of fruits and vegetables each day, additional daily servings don,t ... The human body may only be able to effectively process ... its ability to absorb important nutrients from extra helpings, said ...
(Date:7/30/2014)... July 30, 2014 Florida A&M ... Renee Gordon and biochemistry professor Ngozi Ugochukwu, Ph.D., ... research as Fulbright Scholars. The prestigious Fulbright Scholars ... program that awards grants to students, faculty or ... research abroad. Both Gordon and Ugochukwu will conduct ...
(Date:7/30/2014)... July 30, 2014 BuyCBDOnline.co , ... products, is pleased to announce that it is has ... of top quality products available for immediate shipping. , ... in it's infancy stages," site founder Jason Liss says. ... a wide variety of unique products that are available ...
(Date:7/30/2014)... 30, 2014 The Independent Woman ... be holding 5 free financial workshops in the San ... The goal of these workshops is our collective success, ... of financial empowerment. , These workshops were designed by ... a successful investor, entrepreneur, and bestselling author (Rich Woman ...
(Date:7/30/2014)... TX (PRWEB) July 30, 2014 ... the increase of personal health expenditure as well ... health care system, China diagnostic reagent industry has ... occupy over 90%. In 2013, Chinese in vitro ... RMB16.61 billion came from in vitro diagnostic reagents. ...
Breaking Medicine News(10 mins):Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 2Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 3Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 2Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 3Health News:Delicious, Unique CBD-Rich Hemp Oil Product Debuts from BuyCBDOnline.co 2Health News:Delicious, Unique CBD-Rich Hemp Oil Product Debuts from BuyCBDOnline.co 3Health News:The Independent Woman is Coming to the San Francisco Area in August - Women Helping Women Reach Their Financial Goals 2Health News:The Independent Woman is Coming to the San Francisco Area in August - Women Helping Women Reach Their Financial Goals 3Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 2Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 3Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 4
... of helping military and,vets since 1916, NEW HAVEN, Conn., ... worth of wheelchairs to veterans in,need at four VA Hospital ... long history of K of C service to the men ... has purchased 2000 wheelchairs and partnered,with the Wheelchair Foundation to ...
... orthopaedic surgery feel less pain and leave the ... pouch that delivers local anesthetic agents and,blocks pain ... at The Children,s Hospital of Philadelphia adapted the ... the November 2007 issue of the journal,Anesthesia & ...
... Findings in animal tests may lead to new therapies ... (HealthDay News) -- Blocking a substance called peroxynitrite, a ... prevent the development of tolerance to the pain-relieving effects ... Saint Louis University of Medicine researchers. , They said ...
... Goal to provide access to full healthcare benefits for ... teacher training, student,programs; farmers to compete in the global ... and education programs will be major issues on the ... in Cairo. The,NDP is looking at ways to accelerate ...
... Million Awarded for Medical and Dental Clinic Services, ... Dr. Calvin B. Johnson today announced the award ... Challenge Grants to expand access to,primary medical and ... grants are awarded to nonprofit organizations, local governments,and ...
... HAVEN, Conn., Nov. 2 RHEI Pharmaceuticals, Inc., ... medicines to the China market, will be presenting, ... Healthcare Conference on Monday,November 5, 2007 at 2:20 ... turnkey solution for any,company wishing to gain access ...
Cached Medicine News:Health News:Knights of Columbus to Distribute Wheelchairs to Veterans in Need 2Health News:Anesthesia Pouch Allows Children to Go Home Sooner After Surgery 2Health News:Anesthesia Pouch Allows Children to Go Home Sooner After Surgery 3Health News:Blocking Potent Oxidant Could Prevent Morphine Tolerance 2Health News:Social Justice Issues Take Main Stage at Egypt's National Democratic Party Convention 2Health News:PA Health Department Awards Community Primary Care Challenge Grants 2
(Date:7/29/2014)... -- Sequenom, Inc. (NASDAQ: SQNM ), a life ... total revenues of $39.8 million for the second quarter ... of $24.5 million for the second quarter of 2013. ... sold on May 30, 2014, has been accounted for ... been excluded from continuing operations for all periods. ...
(Date:7/29/2014)...  EnteroMedics Inc. (NASDAQ: ETRM ), the ... obesity, metabolic diseases and other gastrointestinal disorders, today announced ... August 7, 2014 at 11:00 AM Eastern Time to ... 30, 2014 and to provide a business update. ... conference call may be accessed by dialing (877) 280-7473 ...
(Date:7/29/2014)... 2014  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... specific pathogens that cause serious infections and diseases, announced ... in the Company,s stock, the NYSE MKT (the "Exchange") ... practice. The Company stated that its policy is not ... Synthetic Biologics, Inc. Synthetic Biologics, Inc. (NYSE ...
Breaking Medicine Technology:Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 2Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 3Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 4Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 5Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 6Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 7Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 8Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 9Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 10Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 11Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 12Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 13Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 14Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 15Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 16EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 2EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 3Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity 2
... diagnosisTAMPA, Fla., May 14 Moffitt Cancer ... have signed a license agreement on phospholipid ... been granted exclusive worldwide rights to Moffitt,s interests in ... maintenance fees, and royalties on sales. Moffitt and Frantz ...
... indicate statistically significant improvement in ACR20 responses over ... MEDX ) today announced that the ... active rheumatoid arthritis (RA) receiving methotrexate successfully met ... recently completed 70-patient multi-center, randomized, double-blind, placebo-controlled Phase ...
Cached Medicine Technology:Moffitt Cancer Center Signs Licensing Agreement with Frantz BioMarkers, LLC 2Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 2Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 3Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 4
... benefits of fibre bronchoscopy: The HF-compatible V ... all other fibre bronchoscopes are measured., ... PENTAX, including the FB-19TV, FB-18V and FB-15V ... and the pediatric FB-8V, offer much better ...
... therapeutic fiberoptic bronchoscopes offers ... channel with a slim ... channel allows for improved ... of cytology brushes. The ...
... from the latest 60 series bronchoscopes., ... range, focussing on providing clinicians with ... Olympus has a impressive range of ... in the respiratory tract to meet ...
... High performance fiberoptic imaging from ... ,Olympus has improved its fiberscope range, ... specifications and enhanced image performance. Olympus ... instruments for diagnosis and therapy in ...
Medicine Products: